What we do
Bioinformatics
Bioinformatics and Artificial Intelligence are strategically combined at Leukocare to explore a broader design space than conventional approaches to reach optimal formulations in less time at lower costs. Leukocare’s AI and bioinformatics approach is superior to empirical science: shifting from in vitro to in silico —quality over quantity:
Increased quality: AI allows coverage of a broader design space
Find new ideas for formulation using uncommon combinations
- Better Quality of formulations
Reduced development time by shifting in vitro to in silico
Replace assays by deep learning
- Algorithms to predict stabilizing formulations
- Design of experiments instead of high-throughput screening
Enhanced efficiency by intelligent algorithms
Enhanced efficiency by intelligent algorithms
- Web crawler to trace and compile information from the internet
Key elements of Leukocare’s Bioinformatics approach:
Custom made deep learning algorithms, proprietary web crawler and database for formulation prediction:
Efficient, statistically-proven experiments implemented by Design of Experiment (DoE) methodology to substitute traditional high-throughput screening (HTS) > customized statistical software for experimental DoE planning and data evaluation. (©Stella Grosso, MSc. MSc.)
